3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer

References

• HutchinsonLBreast cancer: Challenges, controversies, breakthroughsNature Reviews Clinical Oncology20107669670
   PubMed Web of Science ®Google Scholar
• HaraKYonezawaKSakaueH1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cellsProc Natl Acad Sci U S A19949116741574198052599
   PubMed Web of Science ®Google Scholar
• WennströmSHawkinsPCookeFActivation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane rufflingCurr Biol1994453853937922352
   PubMed Web of Science ®Google Scholar
• OkadaTKawanoYSakakibaraTHazekiOUiMEssential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmanninJ Biol Chem19942695356835738106400
   PubMed Web of Science ®Google Scholar
• DudekHDattaSRFrankeTFRegulation of neuronal survival by the serine-threonine protein kinase AktScience199727553006616659005851
   PubMed Web of Science ®Google Scholar
• Kauffmann-ZehARodriguez-VicianaPUlrichESuppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKBNature199738566165445489020362
   PubMed Web of Science ®Google Scholar
• AhmedNNGrimesHLBellacosaAChanTOTsichlisPNTransduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinaseProc Natl Acad Sci U S A1997948362736329108028
   PubMed Web of Science ®Google Scholar
• CantleyLCThe phosphoinositide 3-kinase pathwayScience200229655731655165712040186
   PubMed Web of Science ®Google Scholar
• FyffeCBuusRFalascaMGenetic and epigenetic regulation of phosphoinositide 3-kinase isoformsCurr Pharm Des201319468068623016860
   PubMed Web of Science ®Google Scholar
• HaslamRJKoideHBHemmingsBAPleckstrin domain homologyNature199336364273093108497315
   PubMed Web of Science ®Google Scholar
• HarlanJEHajdukPJYoonHSFesikSWPleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphateNature199437164931681708072546
   PubMed Web of Science ®Google Scholar
• LemmonMAFalascaMSchlessingerJFergusonKRegulatory recruitment of signalling molecules to the cell membrane by pleckstrinhomology domainsTrends Cell Biol19977623724217708952
   PubMed Web of Science ®Google Scholar
• AlessiDRJamesSRDownesCPCharacterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase BalphaCurr Biol1997742612699094314
   PubMed Web of Science ®Google Scholar
• BurgeringBMCofferPJProtein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transductionNature199537665415996027637810
   PubMed Web of Science ®Google Scholar
• StephensLAndersonKStokoeDProtein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase BScience199827953517107149445477
   PubMed Web of Science ®Google Scholar
• ManningBDCantleyLCAKT/PKB signaling: navigating downstreamCell200712971261127417604717
   PubMed Web of Science ®Google Scholar
• SongMSSalmenaLPandolfiPPThe functions and regulation of the PTEN tumour suppressorNat Rev Mol Cell Biol201213528329622473468
   PubMed Web of Science ®Google Scholar
• OdaKStokoeDTaketaniYMcCormickFHigh frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinomaCancer Res20056523106691067316322209
   PubMed Web of Science ®Google Scholar
• SamuelsYWangZBardelliAHigh frequency of mutations of the PIK3CA gene in human cancersScience2004304567055415016963
   PubMed Web of Science ®Google Scholar
• SamuelsYWaldmanTOncogenic mutations of PIK3CA in human cancersCurr Top Microbiol Immunol2010347214120535651
   PubMed Web of Science ®Google Scholar
• KangSBaderAGVogtPKPhosphatidylinositol 3-kinase mutations identified in human cancer are oncogenicProc Natl Acad Sci U S A2005102380280715647370
   PubMed Web of Science ®Google Scholar
• BachmanKEArganiPSamuelsYThe PIK3CA gene is mutated with high frequency in human breast cancersCancer Biol Ther20043877277515254419
   PubMed Web of Science ®Google Scholar
• FalascaMMaffucciTRegulation and cellular functions of class II phosphoinositide 3-kinasesBiochem J2012443358760122507127
   PubMed Web of Science ®Google Scholar
• VanhaesebroeckBGuillermet-GuibertJGrauperaMBilangesBThe emerging mechanisms of isoform-specific PI3K signallingNat Rev Mol Cell Biol201011532934120379207
   PubMed Web of Science ®Google Scholar
• EdlingCESelvaggiFBuusRKey role of phosphoinositide 3-kinase class IB in pancreatic cancerClin Cancer Res201016204928493720876794
   PubMed Web of Science ®Google Scholar
• MeadowsSAVegaFKashishianAPI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphomaBlood201211981897190022210877
   PubMed Web of Science ®Google Scholar
• CastilloJJFurmanMWinerESCAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignanciesExpert Opin Investig Drugs20122111522
   PubMed Web of Science ®Google Scholar
• HoellenriegelJMeadowsSASivinaMThe phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemiaBlood2011118133603361221803855
   PubMed Web of Science ®Google Scholar
• LannuttiBJMeadowsSAHermanSECAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viabilityBlood2011117259159420959606
   PubMed Web of Science ®Google Scholar
• HermanSEGordonALWagnerAJPhosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signalsBlood2010116122078208820522708
   PubMed Web of Science ®Google Scholar
• LinHJHsiehFCSongHLinJElevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancerBr J Cancer200593121372138116288304
   PubMed Web of Science ®Google Scholar
• VasudevanKMBarbieDADaviesMAAKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerCancer Cell2009161213219573809
   PubMed Web of Science ®Google Scholar
• RaimondiCFalascaMTargeting PDK1 in cancerCurr Med Chem201118182763276921568903
   PubMed Web of Science ®Google Scholar
• PearceLRKomanderDAlessiDRThe nuts and bolts of AGC protein kinasesNat Rev Mol Cell Biol201011192220027184
   PubMed Web of Science ®Google Scholar
• WickMJRamosFJChenHQuonMJDongLQLiuFMouse 3-phosphoinositide-dependent protein kinase-1 undergoes dimerization and trans-phosphorylation in the activation loopJ Biol Chem200327844429134291912923190
   PubMed Web of Science ®Google Scholar
• CurrieRAWalkerKSGrayARole of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1Biochem J1999337Pt 35755839895304
   PubMed Web of Science ®Google Scholar
• MastersTACallejaVArmoogumDARegulation of 3-phosphoinositide-dependent protein kinase 1 activity by homodimerization in live cellsSci Signal20103145ra7820978239
   PubMed Web of Science ®Google Scholar
• MoraAKomanderDvan AaltenDMAlessiDRPDK1, the master regulator of AGC kinase signal transductionSemin Cell Dev Biol200415216117015209375
   PubMed Web of Science ®Google Scholar
• SteckPAPershouseMAJasserSAIdentification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNat Genet19971543563629090379
   PubMed Web of Science ®Google Scholar
• LiJYe nCLiawDPTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancerScience19972755308194319479072974
   PubMed Web of Science ®Google Scholar
• PodsypaninaKEllensonLHNemesAMutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systemsProc Natl Acad Sci U S A1999964156315689990064
   PubMed Web of Science ®Google Scholar
• Di CristofanoAPesceBCordon-CardoCPandolfiPPPten is essential for embryonic development and tumour suppressionNat Genet19981943483559697695
   PubMed Web of Science ®Google Scholar
• QiuWSchönlebenFLiXPIK3CA mutations in head and neck squamous cell carcinomaClin Cancer Res20061251441144616533766
   PubMed Web of Science ®Google Scholar
• CarénHFranssonSEjeskärKKognerPMartinssonTGenetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumoursBr J Cancer200797101416142417940511
   PubMed Web of Science ®Google Scholar
• LiuPMorrisonCWangLIdentification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencingCarcinogenesis20123371270127622510280
   PubMed Web of Science ®Google Scholar
• DituriFMazzoccaALupoLPI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinomaInt J Cancer2012130112505251321796621
   PubMed Web of Science ®Google Scholar
• XieYAbelPWKiruiJKIdentification of upregulated phosphoinositide 3-kinase γ as a target to suppress breast cancer cell migration and invasionBiochem Pharmacol201385101454146223500535
   PubMed Web of Science ®Google Scholar
• KangSDenleyAVanhaesebroeckBVogtPKOncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinaseProc Natl Acad Sci U S A200610351289129416432180
   PubMed Web of Science ®Google Scholar
• BayascasJRLeslieNRParsonsRFlemingSAlessiDRHypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN(+/−) miceCurr Biol200515201839184616243031
   PubMed Web of Science ®Google Scholar
• PearnLFisherJBurnettAKDarleyRLThe role of PKC and PDK1 in monocyte lineage specification by RasBlood2007109104461446917255356
   PubMed Web of Science ®Google Scholar
• BholaNEFreilinoMLJoyceSCAntitumor mechanisms of targeting the PDK1 pathway in head and neck cancerMol Cancer Ther20121161236124622491800
   PubMed Web of Science ®Google Scholar
• FujiwaraSKawanoYYukiHPDK1 inhibition is a novel therapeutic target in multiple myelomaBr J Cancer2013108117017823321518
   PubMed Web of Science ®Google Scholar
• EserSReiffNMesserMSelective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancerCancer Cell201323340642023453624
   PubMed Web of Science ®Google Scholar
• TanJLeePLLiZB55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancerCancer Cell201018545947121075311
   PubMed Web of Science ®Google Scholar
• MaurerMSuTSaalLH3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinomaCancer Res200969156299630619602588
   PubMed Web of Science ®Google Scholar
• NagashimaKShumwaySDSathyanarayananSGenetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitorJ Biol Chem201128686433644821118801
   PubMed Web of Science ®Google Scholar
• FinlayDKSinclairLVFeijooCPhosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytesJ Exp Med2009206112441245419808258
   PubMed Web of Science ®Google Scholar
• PinnerSSahaiEPDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoENat Cell Biol200810212713718204440
   PubMed Web of Science ®Google Scholar
• RaimondiCChikhAWheelerAPMaffucciTFalascaMA novel regulatory mechanism links PLCγ1 to PDK1J Cell Sci2012125Pt 133153316322454520
   PubMed Web of Science ®Google Scholar
• MuranenTAGrecoDFagerholmRKilpivaaraOKämpjärviKAittomäkiKBlomqvistCHeikkiläPBorgANevanlinnaHBreast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implicationsBreast Cancer Res2011135R9021542898
   PubMed Web of Science ®Google Scholar
• ChoucairKAGuérardKPEjdelmanJThe 16p13.3 (PDPK1) Genomic gain in prostate cancer: a potential role in disease progressionTransl Oncol20125645346023401739
   PubMed Web of Science ®Google Scholar
• XieZYuanHYinYZengXBaiRGlazerRI3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinasesBMC Cancer200667716551362
   PubMed Web of Science ®Google Scholar
• GagliardiPAdi BlasioLOrsoF3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent mannerNeoplasia201214871973122952425
   PubMed Web of Science ®Google Scholar
• BaxiSMTanWMurphySTSmealTYinMJTargeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cellsPLoS One2012710e4840223119004
   PubMed Web of Science ®Google Scholar
• LiuYWangJWuMDown-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cellsMol Cancer Res20097694495419531564
   PubMed Web of Science ®Google Scholar
• FanRKimNGGumbinerBMRegulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1Proc Natl Acad Sci U S A201311072569257423359693
   PubMed Web of Science ®Google Scholar
• WangGMWongHYKonishiHSingle copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formationCancer Res201373113248326123580570
   PubMed Web of Science ®Google Scholar
• WuJDauchyRTTirrellPCLight at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast cancer xenograftsCancer Res20117172622263121310824
   PubMed Web of Science ®Google Scholar
• MedinaJRSelective 3-phosphoinositide-dependent kinase 1 (PDK1) inhibitors: dissecting the function and pharmacology of PDK1J Med Chem20135672726273723448267
   PubMed Web of Science ®Google Scholar
• PeiferCAlessiDRSmall-molecule inhibitors of PDK1Chem Med Chem20083121810183818972468
   PubMed Web of Science ®Google Scholar
• FalascaMChiozzottoDGodageHYA novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphateBr J Cancer2010102110411420051961
   PubMed Web of Science ®Google Scholar
• NajafovASommerEMAxtenJMDeyoungMPAlessiDRCharacterization of GSK2334470, a novel and highly specific inhibitor of PDK1Biochem J2011433235736921087210
   PubMed Web of Science ®Google Scholar
• IornsELordCJAshworthAParallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitizationBiochem J2009417136137018976239
   PubMed Web of Science ®Google Scholar
• FalascaMPI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugsCurr Pharm Des201016121410141620166984
   PubMed Web of Science ®Google Scholar
• LauringJParkBHWolffACThe phosphoinositide-3-kinase-Akt-mTOR pathway as a therapeutic target in breast cancerJ Natl Compr Canc Netw201311667067823744866
   PubMed Web of Science ®Google Scholar
• YardleyDACombining mTOR inhibitors with chemotherapy and other targeted therapies in advanced breast cancer: rationale, clinical experience, and future directionsBreast Cancer (Auckl)2013772223492649
   PubMedGoogle Scholar
• NajafovAShpiroNAlessiDRAkt is efficiently activated by PIF-pocket-and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitorsBiochem J2012448228529523030823
   PubMed Web of Science ®Google Scholar
• KlementGLGoukassianDHlatkyLCarrozzaJMorganJPYanXCancer therapy targeting the HER2-PI3K pathway: potential impact on the heartFront Pharmacol2012311322754526
   PubMed Web of Science ®Google Scholar
• FinlayDKRosenzweigESinclairLVPDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cellsJ Exp Med2012209132441245323183047
   PubMed Web of Science ®Google Scholar